Answers are grounded in this paper and cite their sources.
This work demonstrates a label-free test that improves viral detection in bioanalysis, suggesting potential for efficient point-of-care testing.
DNAzymes have significantly enriched the toolbox for point‐of‐care testing (POCT); however, their inferior biostability and reliance on costly chemical labeling limit their broader applicability in high‐throughput viral sample analysis. Herein, we constructed a label‐free DNAzyme POCT platform for the accurate detection of influenza virus, with low cost (approximately US$0.20 per test). The simple yet robust viral detection system consists merely of a phosphate‐transferase‐mimicking DNAzyme (P‐Dz) with a newly discovered highly‐efficient small‐molecule substrate, 6,8‐difluoro‐4‐methylumbelliferyl phosphate (DiFMUP). Target viral RNA could specifically restore the catalytically active conformation of P‐Dz for initiating the phosphate transfer reaction from DiFMUP and for producing a high fluorescence signal. Without the prerequisite of laborious and expensive chemical labeling of DNA substrate, a readily accessible test filter strip (TFS) was introduced into the system, enabling the interpretation of fluorescence readout via smartphone visualization and thereby achieving the amplified detection of various viral RNA targets. This label‐free DNAzyme platform provides a cost‐effective and portable platform for bioanalysis, with considerable potential in epidemiological diagnostics and therapeutic monitoring.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: